BAMCO Inc’s NextCure NXTC Stock Holding History

BAMCO Inc’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-64	Closed	-$28K	–	357
2020 Q1	$28K	Hold	64	–	–	﹤0.01%	330
2019 Q4	$43K	Sell	64 -50	-44%	-$25.1K	﹤0.01%	346
2019 Q3	$42K	Buy	+114	New	+$37.1K	﹤0.01%	340

Other funds holding NXTC

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc's NXTC Position: Q2 2020 in Review

BAMCO Inc sold out of NextCure (NXTC) in Q2 2020, closing a stake of 64 shares — an estimated $28K sold.

BAMCO Inc first reported a position in NXTC in Q3 2019 and held it in 3 quarters. The position peaked at $43K in Q4 2019. 88 funds tracked by Wall St. Rank hold NXTC as of Q2 2020.

BAMCO Inc reported no remaining NextCure position as of Q2 2020 after selling out during the quarter.
BAMCO Inc sold 64 NextCure shares in Q2 2020, an estimated $28K.
BAMCO Inc first reported a position in NextCure in Q3 2019 and held it in 3 quarters.
BAMCO Inc's NextCure position peaked at $43K in Q4 2019.
88 funds tracked by Wall St. Rank held NextCure as of Q2 2020.

Based on BAMCO Inc's 13F filing for Q2 2020, filed 14 Aug 2020.